Company intelligence / Profile preview

MarocVax

Benslimane, Casablanca-Settat, Morocco

Ownership: Private
Development stage: Other

Overview

MarocVax, often associated with the SENSYO Pharmatech project, is a large-scale vaccine manufacturing initiative in Morocco designed to ensure vaccine sovereignty for the African continent. Launched under the patronage of King Mohammed VI, the company operates a state-of-the-art facility in Benslimane known as the 'Lion Unit.' The facility is designed to manufacture a wide range of vaccines, including those for COVID-19, using various technologies such as mRNA and viral vectors. MarocVax aims to become a leading biotechnology hub in Africa, providing end-to-end fill-and-finish and drug substance manufacturing services.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologicmRNA-based drugs
Industry: Pharma

Partnerships

RecipharmSinopharmGovernment of Morocco

Beyond the preview

Go deeper on MarocVax.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MarocVax.

Explore the full profile